Navigation Links
100,000 Bird Flu Vaccine Doses to Be Destroyed

In the next couple of months, 100,000 doses of the country's first vaccine against bird flu will be destroyed because the laboratory that developed it has found no takers //and the expiry date is fast approaching.

It was in July last year that the High Security Animal Disease Laboratory (HSADL) here developed India's first vaccine against bird flu. It had preserved about 100,000 doses of the vaccine, each costing just 27 paise.

But no drug manufacturing company has contacted the research institute so far to buy either these doses or the formula for commercial use, an official of the institute said on condition of anonymity.

"We are now left with no option but to destroy them after 10 weeks or so since the total life of the doses is one year. They would turn ineffective after 12 months from the date of their preparation," he rued.

Talking about the vaccine's efficacy, he said: "The vaccine can be used immediately after a bird flu outbreak to control the spread of the virus as well as for vaccination in anticipation of an outbreak."

"The immune response is good and the protection offered by the vaccine has been found to be above 90 percent. The protection should last up to six months for hens. For a broiler it needs to be administered only once."

HSADL, which is equipped with the technique of identifying the avian influenza virus among poultry, tested thousands of bird samples including droppings of migratory birds last year after the first strains of the deadly H5N1 virus were detected in western Madhya Pradesh, Gujarat and Maharashtra.

"The Indian Council of Agricultural Research entrusted us with the job of developing the vaccine soon after the first outbreak of the disease in February 2006 and also promptly provided us Rs.80 million to help us accomplish the challenging task," said HSADL Joint Director H.K. Pradhan.

Pradhan and his special team of scientists swung into act
'"/>




Page: 1 2

Related medicine news :

1. Free AIDS Treatment For 100,000 Patients: Indian Govt
2. Hospital Trust Fined £100,000 after Patient Deat
3. Jolie-Pitt Donate $100,000 for Sudan Hospital
4. Vaccine to quit smoking?
5. First Vaccine Designed for Africa Cleared for Testing in Humans
6. Vaccine for Alzheimer’s diseas
7. Health Officials Recommend Flu Vaccine
8. Smallpox Vaccine May Help Fight Cervical Cancer
9. Panacea Biotech To Market Anthrax Vaccine
10. New Prostate Cancer Vaccine Shows Promise
11. Drug Firm Offers to Donate Smallpox Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bird Flu Vaccine Doses Destroyed

(Date:9/2/2015)... ... , ... The CRISPR-Cas9 system introduces double-strand DNA breaks at a ... either a chimeric single guide RNA (sgRNA) or two short RNAs (a CRISPR RNA ... or crRNA) to create a break in the target DNA that causes functional protein ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 02, 2015 , ... ... company, American Well Corp., contracted to handle the telehealth services of more than 12 ... Blue Cross and Blue Shield Plans takes a look this growing trend, interviewing executives ...
(Date:9/2/2015)... ... ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, Pa.-based ... Sam Keen based on his new book which he co-authored with his son, Gifford ...
(Date:9/2/2015)... ... 2015 , ... RxNT , an innovative software solutions ... cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks the ... in health technology, RxNT was one of the first to build an ePrescribing ...
Breaking Medicine News(10 mins):Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2
... decision making on issues whose consequences will only be ... annual Addiction Science Awards at this year,s Intel International ... science competition for high school students. The Intel ISEF ... Thursday night in Los Angeles. The awards were presented ...
... best efforts of scientists, in many cases the underlying causes of ... team of Australian and Swedish researchers, however, will go a long ... published in Science this week, a small set of ... are crucial to unravelling the secrets of male infertility. ...
... , THURSDAY, May 12 (HealthDay News) -- Representatives ... that she entered a facility for surgery to remove ... that can occur on the meninges, the brain,s protective ... who has been monitoring this for years, and a ...
... HealthDay Reporter , FRIDAY, May 13 (HealthDay News) -- Every ... to hungry students in the fourth-largest school district in the ... food and menu management for the Miami-Dade County Public Schools, ... that goal. The move by the U.S. Department of ...
... levels of cardiac troponin T (cTnT) or I (cTnI) ... of all-cause mortality and long-term adverse events such as ... nonemergent percutaneous coronary intervention (PCI) could improve long-term outcomes ... online in Catheterization and Cardiovascular Interventions , a ...
... This press release is available in French . ... it,s definitely going on., A recent survey, led by McGill ... reports that one in five respondents physicians and psychiatrists ... placebo. Moreover, an even higher proportion of psychiatrists (more than ...
Cached Medicine News:Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Research breakthrough on male infertility 2Health News:Brain Surgery for Mary Tyler Moore to Remove Benign Tumor 2Health News:School Systems Struggle With Lunchroom Costs 2Health News:Elevated protein levels in cardiac muscles could predict mortality following angioplasty 2Health News:The power of placebos 2
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... The quantum dot market report analyzes the ecosystem of the ... product includes medical devices, display, and others. The others segment ... storage, QD laser, and transistor. The application segment covers the ... The report also provides the geographic view for major regions ... Europe , Asia-Pacific (APAC), and ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... (Nasdaq: ALTH ) today announced the initiation ... multi-center dose,escalation study of the Company,s targeted chemotherapeutic ... non-Hodgkin,s lymphoma (NHL). "We are pleased to ... Cagnoni, M.D., Chief Medical Officer of Allos. "RH1 ...
... Appropriate Patient Selection Criteria for Future Field ... ... Corporation (Nasdaq: DVAX ) presented yesterday a detailed,analysis of data ... for ragweed allergic rhinitis. The,data were reported yesterday at the annual ...
Cached Medicine Technology:Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 2Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 3
Full Handle Laseredge Implant Blade Knife, 5.2 mm round tip. Blade dimension: 16.5 mm x 5.2 mm x 3.8 mm x 2.4 mm....
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: